Shane M. Ward's Insider Trades & SAST Disclosures
Shane M. Ward's most recent trade in Cidara Therapeutics Inc was a trade of 50,000 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on March 31, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Shane M. Ward.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cidara Therapeutics Inc | Shane M. Ward | COO & CLO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2025 | 50,000 | 50,000 | - | - | Employee Stock Option (right to buy) | |
| Cidara Therapeutics Inc | Shane M. Ward | COO & CLO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2025 | 25,000 | 39,674 (0%) | 0% | 0 | Common Stock | |
| Cidara Therapeutics Inc | Shane M. Ward | COO & CLO | Sale of securities on an exchange or to another person at price $ 21.96 per share. | 11 Mar 2025 | 1,664 | 14,674 (0%) | 0% | 22.0 | 36,542 | Common Stock |
| Cidara Therapeutics Inc | Shane M. Ward | COO & CLO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2024 | 135,540 | 135,540 | - | - | Employee Stock Option (right to buy) | |
| Cidara Therapeutics Inc | Shane M. Ward | COO & CLO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2024 | 250,000 | 250,000 | - | - | Employee Stock Option (right to buy) | |
| Cidara Therapeutics Inc | Shane M. Ward | COO & CLO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2024 | 120,000 | 318,770 (0%) | 0% | 0 | Common Stock | |
| Cidara Therapeutics Inc | Shane M. Ward | COO & CLO | Sale of securities on an exchange or to another person at price $ 0.67 per share. | 11 Mar 2024 | 20,473 | 198,770 (0%) | 0% | 0.7 | 13,713 | Common Stock |
| Cidara Therapeutics Inc | Shane M. Ward | COO & CLO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2023 | 253,333 | 253,333 | - | - | Employee Stock Option (right to buy) | |
| Cidara Therapeutics Inc | Shane M. Ward | COO & CLO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2023 | 126,667 | 211,243 (0%) | 0% | 0 | Common Stock | |
| Cidara Therapeutics Inc | Shane M. Ward | COO & CLO | Sale of securities on an exchange or to another person at price $ 1.53 per share. | 13 Mar 2023 | 4,329 | 84,576 (0%) | 0% | 1.5 | 6,623 | Common Stock |
| Cidara Therapeutics Inc | Shane M. Ward | CHIEF LEGAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2022 | 70,000 | 70,000 | - | - | Employee Stock Option (right to buy) | |
| Cidara Therapeutics Inc | Shane M. Ward | CHIEF LEGAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2022 | 69,027 | 104,027 (0%) | 0% | 0 | Common Stock | |
| Cidara Therapeutics Inc | Shane M. Ward | CHIEF LEGAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2022 | 35,000 | 35,000 (0%) | 0% | 0 | Common Stock | |
| Cidara Therapeutics Inc | Shane M. Ward | CHIEF LEGAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.83 per share. | 31 Mar 2022 | 23,122 | 80,905 (0%) | 0% | 0.8 | 19,191 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges